Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Retained Earnings (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) recorded Retained Earnings of $3.74 billion in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 1.8% from $3.81 billion a year earlier and down 0.6% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Retained Earnings (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories reported Retained Earnings of $3.75 billion, up 1.5% from FY2025.

  • Annual Retained Earnings has increased for 12 straight fiscal years, with a five-year compound annual growth rate of 12.0% (FY2021 to FY2026).
  • Across earlier fiscal years, Retained Earnings came in at $3.7 billion in FY2025 (+16.1%), $3.18 billion in FY2024 (+21.3%), $2.62 billion in FY2023 (+13.3%) and $2.32 billion in FY2022 (+8.6%).
  • Quarterly Retained Earnings has ranged from $2.32 billion in fiscal Q4 2022 to $3.9 billion in fiscal Q3 2026 over the past five years.
  • On a year-over-year basis, Retained Earnings rose in six of the last eight quarters, with growth averaging 8.2%.
  • Peak year-over-year performance for Retained Earnings in the last five years was growth of 22.7% in fiscal Q3 2024, against a decline of 2.6% in fiscal Q1 2027 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $3.76 billion (Q1 2027), $3.73 billion (Q4 2026) and $3.9 billion (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 37.97 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 168.36 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -16.19 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 66.22 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 14.07 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -19.81 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn 3.11 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 115.33 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 3.74 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.74 Bn
Jun 30, 2026 3.76 Bn
Mar 31, 2026 3.73 Bn
Dec 31, 2025 3.90 Bn
Sep 30, 2025 3.81 Bn
Jun 30, 2025 3.86 Bn
Mar 31, 2025 3.69 Bn
Dec 31, 2024 3.49 Bn
Sep 30, 2024 3.41 Bn
Jun 30, 2024 3.35 Bn
Mar 31, 2024 3.18 Bn
Dec 31, 2023 3.06 Bn
Sep 30, 2023 2.86 Bn
Jun 30, 2023 2.80 Bn
Mar 31, 2023 2.63 Bn
Dec 31, 2022 2.50 Bn
Sep 30, 2022 2.38 Bn
Jun 30, 2022 2.38 Bn
Mar 31, 2022 2.32 Bn
Dec 31, 2021 2.35 Bn
API Access

Dr Reddys Laboratories Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=RDY&period=max&api_key=YOUR_API_KEY